A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the effectiveness and safety of topiramate
(an epilepsy medication) compared with placebo in the prevention of migraine.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.